-
Product Insights
NewLikelihood of Approval Analysis for Hypertrophic Cardiomyopathy
Overview How likely is it that the drugs in Hypertrophic Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertrophic Cardiomyopathy Overview Hypertrophic cardiomyopathy (HCM) is a disease in which the...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertension
Overview How likely is it that the drugs in Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertension Overview Hypertension, commonly known as high blood pressure, is a chronic medical...
-
Product Insights
NewLikelihood of Approval Analysis for Cardiomyopathy
Overview How likely is it that the drugs in Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiomyopathy Overview Cardiomyopathy a disease of the heart muscle, where the walls of...
-
Product Insights
NewLikelihood of Approval Analysis for Pulmonary Hypertension
Overview How likely is it that the drugs in Pulmonary Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Hypertension Overview Pulmonary hypertension (PH) is a rare condition marked by...
-
Sector Analysis
NewTranscatheter Pulmonary Valve Replacement (TPVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Transcatheter Pulmonary Valve Replacement (TPVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Transcatheter Pulmonary Valve Replacement (TPVR) market for the year 2020 and beyond. Transcatheter Pulmonary Valve Replacement is used treatment for infant has a malformed heart at birth and adults with congenital heart disease. It replaces narrowed and leaky pulmonary valves to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986141 in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986141 in Coronary Artery Disease (CAD) (Ischemic Heart Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986141 in Coronary Artery Disease (CAD) (Ischemic...
-
Product Insights
NewLikelihood of Approval Analysis for Atrial Fibrillation
Overview How likely is it that the drugs in Atrial Fibrillation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atrial Fibrillation Overview Atrial fibrillation is an irregular and often rapid heart...
-
Product Insights
NewLikelihood of Approval Analysis for Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that the drugs in Chronic Kidney Disease (Chronic Renal Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Kidney Disease (Chronic Renal Failure) Overview Chronic...
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...